CERTOLIZUMAB PEGOL
certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices
CERTOLIZUMAB PEGOL (11322X)
11322X
Manner of administration:Injection
Restriction
Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 24 months)
Restriction
Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 24 months)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 6 | # of repeats: 0 | DPMQ: $2,977.05 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Cimzia | |||||